Cargando…
Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
INTRODUCTION: The Gleason score is a strong prognostic factor for treatment failure in pathologically organ-confined prostate cancer (pT2) treated by radical prostatectomy (RP). However, within each Gleason score, there is clinical heterogeneity with respect to treatment outcome, even in patients wi...
Autores principales: | Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo, Salazar, Anibal, Lopez, Marco Antonio, Minzer, Simona, Orrego, Shenda, Guzman, Eghon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605630/ https://www.ncbi.nlm.nih.gov/pubmed/31281431 http://dx.doi.org/10.3332/ecancer.2019.934 |
Ejemplares similares
-
The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2020) -
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
por: Murray, Nigel P, et al.
Publicado: (2020) -
Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone
por: Murray, Nigel P, et al.
Publicado: (2020) -
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
por: Murray, Nigel P, et al.
Publicado: (2019) -
Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
por: Murray, Nigel P, et al.
Publicado: (2018)